Hypermobility also predicts greater fatigue levels
Annual Two-Dose SARS-CoV-2 Vaccination Campaign Beneficial
Second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus single-dose campaign
Enhancing Indoor Ventilation Reduces Respiratory Virus Risk
It is essential to remember that various airborne viruses spread throughout the year, even as respiratory diseases continue to decline from their peak in late December 2023.
Viruses such as influenza and Respiratory Syncytial virus displayed both seasonal and regional outbreaks last winter.
Human respiratory viruses include a broad range of viruses transmitted mainly by infected persons.
Enhancing Indoor Ventilation Reduces Respiratory Virus Risk
It is essential to remember that various airborne viruses spread throughout the year, even as respiratory diseases continue to decline from their peak in late December 2023.
Viruses such as influenza and Respiratory Syncytial virus displayed both seasonal and regional outbreaks last winter.
Human respiratory viruses include a broad range of viruses transmitted mainly by infected persons.
Immunotherapy Drugs Project 18% CAGR
People have been fighting disease since the dawn of time by leveraging whichever solutions were available. In the field of virology, innovative technologies have produced life-saving products for the treatment and prevention of disease.
Over the years, scientific discoveries have propelled the creation of sub-markets such as vaccines, monoclonal antibody therapy, and immunotherapy.
These innovations have empowered the human immune system and positively impacted human health.
Can Vaccines Empower World Tuberculosis Day
As World Tuberculosis Day is recognized today, health leaders are worried about the increasing number of TB cases in industrialized countries.
While TB outbreaks are typically associated with countries like India, the United States (U.S.) has also experienced an increase in the number of TB cases and deaths over the past three years.
In 2022, the U.S. reported 8,331 TB cases, representing a 5.9% increase compared with 2021.
Specifically, four international gateway states, California, Texas, New York, and Florida, reported about 50% of all TB cases in the U.S.
Over 1,100 Zika Cases Confirmed in 2024
According to the latest data from the U.K. Health Security Agency (UKHSA), mosquito-borne infections associated with travel are increasing and returning to levels last recorded before the recent pandemic.
This UKHSA warning was issued on March 21, 2024, and is particularly concerning for diseases like dengue, malaria, and Zika. It emphasizes the importance of taking precautions to minimize health risks while traveling.
Are New Tuberculosis Vaccines Really Needed
Due to the unexpected three-year increase in tuberculosis (TB) cases in the United States, there is a lot of attention focused on developing new preventive vaccines.
In the United States, the USAID Annual Tuberculosis Report to Congress, FY 2023, indicates about 8,300 individuals were diagnosed with TB in 2022, a 5% increase in the U.S. from the previous year, and global case notifications increased over the last year by 70%.
Fewer Cases of Fungal Diseases Coincided With Start of COVID-19
Fewer cases of each disease occurred in spring versus other seasons in 2020, and most cases occurred in the fall
Yellow Fever Outbreaks Cause 11% Case Fatality Rate
Since the ancient Yellow Fever virus was identified in Africa centuries ago, the continent has reported extensive, deadly outbreaks.
In 2023, this unfortunate trend continued.
The World Health Organization (WHO) today published Disease Outbreak News confirming that the African Region continues to confront Yellow Fever outbreaks.